Literature DB >> 21617080

Echocardiographic detection of congestive heart failure in postinfarction rats.

Paula F Martinez1, Katashi Okoshi, Leonardo A M Zornoff, Silvio A Oliveira, Dijon H S Campos, Aline R R Lima, Ricardo L Damatto, Marcelo D M Cezar, Camila Bonomo, Daniele M Guizoni, Carlos R Padovani, Antonio C Cicogna, Marina P Okoshi.   

Abstract

In studies of congestive heart failure (CHF) treatment, it is essential to select animals with a similar degree of cardiac dysfunction. However, this is difficult to establish without hemodynamic evaluation in rat postinfarction-induced CHF. This study aimed to diagnose CHF in long-term follow-up postinfarction rats using only echocardiographic criteria through a J-tree cluster analysis and Fisher's linear discriminant function. Two sets of sham and infarcted rats were studied. The first was used to perform cluster analysis and the second to prospectively validate the results. Six months after inducing myocardial infarction (MI), rats were subjected to transthoracic echocardiography. Infarct size was measured by histological analysis. Six echocardiographic variables were used in the cluster analysis: left ventricular (LV) systolic dimension, LV diastolic dimension-to-body weight ratio, left atrial diameter-to-body weight ratio, LV posterior wall shortening velocity, E wave, and isovolumetric relaxation time. Cluster analysis joined the rats into one sham and two MI groups. One MI cluster had more severe anatomical and echocardiographic changes and was called MI with heart failure (MI/HF+, n = 24, infarct size: 42.7 ± 5.8%). The other had less severe changes and was called MI without heart failure (MI/HF-, n = 11, infarct size: 32.3 ± 9.9%; P < 0.001 vs. MI/HF+). Three rats with small infarct size (21.6 ± 2.2%) presenting mild cardiac alterations were misallocated in the sham group. Fisher's linear discriminant function was built using these groups and used to prospectively classify additional groups of sham-operated (n = 20) and infarcted rats (n = 57) using the same echocardiographic parameters. The discriminant function therefore detected CHF with 100% specificity and 80% sensitivity considering allocation in MI/HF+ and sham group, and 100% specificity and 58.8% sensitivity considering MI/HF+ and MI/HF- groups, taking into account pathological criteria of CHF diagnosis. Echocardiographic analysis can be used to accurately predict congestive heart failure in postinfarction rats.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21617080     DOI: 10.1152/japplphysiol.01154.2010

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  26 in total

1.  High-intensity resistance training alone or combined with aerobic training improves strength, heart function and collagen in rats with heart failure.

Authors:  Jadson Pereira Alves; Ramiro Barcos Nunes; Daniele da Cunha Ferreira; Giuseppe Potrick Stefani; Rodrigo Boemo Jaenisch; Pedro Dal Lago
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Maximal oxygen uptake and exercise tolerance are improved in rats with heart failure subjected to low-level laser therapy associated with resistance training.

Authors:  Vítor Scotta Hentschke; Lucas Capalonga; Douglas Dalcin Rossato; Júlia Luíza Perini; Jadson Pereira Alves; Giuseppe Potrick Stefani; Marlus Karsten; Mauro Pontes; Pedro Dal Lago
Journal:  Lasers Med Sci       Date:  2016-11-17       Impact factor: 3.161

Review 3.  Surgical and physiological challenges in the development of left and right heart failure in rat models.

Authors:  Michael G Katz; Anthony S Fargnoli; Sarah M Gubara; Elena Chepurko; Charles R Bridges; Roger J Hajjar
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

Review 4.  Smart/stimuli-responsive hydrogels: Cutting-edge platforms for tissue engineering and other biomedical applications.

Authors:  Hussein M El-Husseiny; Eman A Mady; Lina Hamabe; Amira Abugomaa; Kazumi Shimada; Tomohiko Yoshida; Takashi Tanaka; Aimi Yokoi; Mohamed Elbadawy; Ryou Tanaka
Journal:  Mater Today Bio       Date:  2021-12-09

5.  Preventive aerobic training exerts a cardioprotective effect on rats treated with monocrotaline.

Authors:  Francis Lopes Pacagnelli; Ana Karênina Dias de Almeida Sabela; Katashi Okoshi; Thaoan Bruno Mariano; Dijon Henrique Salomé Campos; Robson Francisco Carvalho; Antônio Carlos Cicogna; Luiz Carlo Marques Vanderlei
Journal:  Int J Exp Pathol       Date:  2016-07-01       Impact factor: 1.925

6.  Association between Functional Variables and Heart Failure after Myocardial Infarction in Rats.

Authors:  Bertha F Polegato; Marcos F Minicucci; Paula S Azevedo; Andréa F Gonçalves; Aline F Lima; Paula F Martinez; Marina P Okoshi; Katashi Okoshi; Sergio A R Paiva; Leonardo A M Zornoff
Journal:  Arq Bras Cardiol       Date:  2016-01-26       Impact factor: 2.000

7.  Chemogenetic activation of intracardiac cholinergic neurons improves cardiac function in pressure overload-induced heart failure.

Authors:  Jhansi Dyavanapalli; Aloysius James Hora; Joan B Escobar; John Schloen; Mary Kate Dwyer; Jeannette Rodriguez; Christopher F Spurney; Matthew W Kay; David Mendelowitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-15       Impact factor: 4.733

8.  Heart Failure Mid-Range Ejection Fraction.

Authors:  Paula Felippe Martinez; Marina Politi Okoshi; Katashi Okoshi; Silvio Assis de Oliveira-Junior
Journal:  Arq Bras Cardiol       Date:  2021-01       Impact factor: 2.000

9.  Rutin administration attenuates myocardial dysfunction in diabetic rats.

Authors:  Julliano F C Guimaraes; Bruno P Muzio; Camila M Rosa; Andre F Nascimento; Mario M Sugizaki; Ana A H Fernandes; Antonio C Cicogna; Carlos R Padovani; Marina P Okoshi; Katashi Okoshi
Journal:  Cardiovasc Diabetol       Date:  2015-07-17       Impact factor: 9.951

10.  Combination of ketamine and xylazine exacerbates cardiac dysfunction in severely scalded rats during the shock stage.

Authors:  Yongqiang Feng; Jiake Chai; Wanli Chu; Li Ma; Peipei Zhang; Hongjie Duan
Journal:  Exp Ther Med       Date:  2013-07-10       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.